TESTI, Anna Maria
 Distribuzione geografica
Continente #
NA - Nord America 8.591
EU - Europa 5.773
AS - Asia 1.975
SA - Sud America 90
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 16.476
Nazione #
US - Stati Uniti d'America 8.477
IT - Italia 3.503
SG - Singapore 883
SE - Svezia 738
IN - India 601
CN - Cina 399
FI - Finlandia 349
UA - Ucraina 326
DE - Germania 220
GB - Regno Unito 109
RO - Romania 103
CA - Canada 98
FR - Francia 83
IE - Irlanda 76
RU - Federazione Russa 62
BG - Bulgaria 57
AR - Argentina 49
BR - Brasile 32
BE - Belgio 31
CH - Svizzera 27
TG - Togo 23
NL - Olanda 20
TR - Turchia 20
MX - Messico 15
ES - Italia 14
ID - Indonesia 13
ZA - Sudafrica 10
AE - Emirati Arabi Uniti 9
HK - Hong Kong 9
AL - Albania 8
CL - Cile 8
AT - Austria 7
PL - Polonia 7
IR - Iran 6
LT - Lituania 5
IL - Israele 4
JP - Giappone 4
KR - Corea 4
PK - Pakistan 4
SA - Arabia Saudita 4
DK - Danimarca 3
EU - Europa 3
GH - Ghana 3
GR - Grecia 3
HR - Croazia 3
JO - Giordania 3
MY - Malesia 3
NO - Norvegia 3
EE - Estonia 2
HU - Ungheria 2
LY - Libia 2
ME - Montenegro 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
SC - Seychelles 2
SI - Slovenia 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BY - Bielorussia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 16.476
Città #
Fairfield 977
Chandler 823
Ashburn 672
Singapore 614
Princeton 559
Rome 483
Woodbridge 436
Wilmington 399
Seattle 348
Houston 317
Plano 299
Cambridge 287
Ann Arbor 247
Santa Clara 239
Beijing 237
Des Moines 237
Boston 188
Milan 178
San Paolo di Civitate 164
Millbury 156
Dearborn 128
Lawrence 98
San Diego 96
Jacksonville 88
Andover 86
Bremen 66
Helsinki 64
Toronto 63
Norwalk 60
Dublin 58
Bologna 56
Sofia 56
Florence 55
San Mateo 48
Federal 45
Southend 42
Naples 40
Lamézia 37
New York 36
Turin 34
Ottawa 33
Brussels 29
Moscow 29
Falkenstein 27
Bari 26
Bühl 26
Lomé 23
Falls Church 21
Hefei 19
Mannheim 19
Genoa 18
Torino 18
Kunming 16
Nanjing 16
Palermo 16
Napoli 15
Padova 14
Brescia 13
Catania 13
Venice 13
Buffalo 12
Genova 12
London 12
Ankara 11
Boardman 11
Jakarta 11
Messina 11
Mexico City 10
Ancona 9
Contursi 9
Guangzhou 9
Hong Kong 9
Istanbul 9
Los Angeles 9
Pitesti 9
Atella 8
Dallas 8
Ferrara 8
Jinan 8
Pavia 8
Stockholm 8
Vélizy 8
Alba 7
Birkenhead 7
Campobasso 7
Cattolica 7
Fasano 7
Laurel 7
Menlo Park 7
Muizenberg 7
Pescara 7
Reggio Emilia 7
Reggio Nell'emilia 7
Shenyang 7
Verona 7
Vienna 7
Chongqing 6
Indiana 6
Montepulciano 6
Mountain View 6
Totale 9.851
Nome #
Terapia di salvataggio con il protocollo IEV seguito da chemioterapia ablativa e trapianto autologo in pazienti affetti da Hodgkin refrattari o in recidiva: risultati in 23 pazienti con età <18 anni alla diagnosi. 1.558
Efficacia dell'uso del methotrexate ad alte dosi (HD-MTX 2 g/mq) associato a terapia intratecale protratta con methotrexate, nella prevenzione della recidiva al sistema nervoso centrale in pazienti non sottoposti a radioterapia craniale: esperienza del protocollo AIEOP LLA 95 512
High dose cytarabine and idarubicin for the treatment of advanced acute lymphoblastic leukemia 281
Esperienza con l'imatinib ad intermittenza nei bambini e adolescenti con leucemia mieloide cronica (LMC): risultati e prospettive 213
Protocollo AIEOP LAM 2002/01: risultati preliminari 190
Mitoxantrone, Etoposide e dosi intermedie di ARA-C (protocollo MEC) nel trattamento della leucemia acuta mieloide (LAM) del bambino refrattario o in recidiva 168
Terapia con Idrossiurea in bambini e adolescenti affetti da anemia falciforme nel “real life setting 154
Prevenzione e terapia della meningosi leucemica 141
LOCALIZZAZIONE EXTRAMIDOLLARE DI LAM IN ETÀ PEDIATRICA: IL RUOLO DI UNA CORRETTA E TEMPESTIVA DIAGNOSI 131
Treatment-free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia. 109
Impatto della radioterapia craniale nella leucemia linfoblastica acuta (LLA) T a rischio intermedio con iperleucocitosi (> 100,000 mm3) e prednisone good response (PGR): risultati degli studi AIEOP-ALL 91 e 95 106
Comparative analysis between RQ-PCR and digital-droplet-PCR of immunoglobulin/T-cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia 103
GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. 103
Impact of the COVID-19 pandemic on patients with paediatric cancer in low-income, middle-income and high-income countries: a multicentre, international, observational cohort study 101
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia 99
Epstein-Barr virus–positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus–positive diffuse large B-cell lymphoma of the elderly 96
Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes 92
Atypical chronic myeloid leukemia in a patient with aplastic anemia 92
Leucemia acuta promielocitica del bambino: risultati del protocollo nazionale AIDA (LAP 0493) 89
Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome 87
Central Nervous System Involvement in Relapsed Acute Promyelocytic Leukemia 86
Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: An individual patient data meta-analysis 86
EFFICACIA DEL PEG-IFNΑ-2A IN UN CASO DI POLICITEMIA VERA PEDIATRICA 86
Prognostic value of rhodamine-efflux and MDR-1/p-170 expression in childhood acute leukemia 86
Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia 85
Bone Metabolism and Endocrine Function in Children with Chronic Myeloid Leukemia (CML) Treated with Imatinib during Puberty. 83
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial 83
Childhood high-risk acute lymphoblastic leukemia in first remission: Results after chemotherapy or transplant from the AIEOP ALL 2000 study 79
INDOMETHACIN AS FIRST LINE TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS (LCH). A 20-YEAR EXPERIENCE OF A SINGLE CENTRE. 78
CODOX-M/IVAC (NCI 89-C-41) for children and adolescents with small non-cleaved and large B-cell lymphomas. A 14 years monocentric experience 77
Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience 77
Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications 76
CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: A 15-year monocentric experience. 76
Advanced pediatric myelodysplastic syndromes: Can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool? 75
Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up succesfully treated with chemotherapy alone 72
Twenty years of the Italian Fanconi Anemia Registry: Where we stand and what remains to be learned 72
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. 72
TEL/AML1 Rearrangement Is Rare in Children with Acute Lymphoblastic Leukemia (ALL) and Down Syndrome (DS). Presenting Features and Treatment Outcome in the Experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). 71
Acute promyelocytic leukemia (APL): Comparison between children and adults 71
Umbilical cord blood transplant from unrelated HLA-mismatched donors in children with high risk leukemia 71
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications 69
GIMEMA-AIEOP AIDA Protocol for the Treatment of newly diagnosed Acute Promyelocytic Leukemia (APL) in Children. 69
EFFICACIA E SICUREZZA DELL’IMPIEGO DEI PICC IN PAZIENTI PEDIATRICI AFFETTI DA LEUCEMIA ACUTA: ESPERIENZA MONOCENTRICA 69
Late relapses in acute promyelocytic leukaemia 68
A for the European Group for Blood and Marrow Transplantation (EBMT) Working Party on severe aplastic anemia and the Gruppo Italiano trapianti di Midollo Osseo (GITMO). Antilymphocyte globulin, cyclosporine, prednisolone and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients 68
Terapia della leucemia mieloide acuta del bambino resistente o in recidiva: risultati in 36 casi trattati con il protocollo MEC (Mitoxantrone, Etoposide e dosi intermedie di Ara-C). 68
Porpora trombocitopenica idiomatica (PTI): terapia con alte dosi di desametasone nei bambini e negli adolescenti. [Idiopathic Thrombocytopenic Purpura: Therapy with high doses of desametasone in children and adolescents] 66
Relapse in Childhood "Very High Risk" Acute Lymphoblastic Leukemia Treated with BFM Chemotherapy Has a Dismal Outcome Even When Treated with Transplantation 65
Specific guidelines including multidisciplinary approach is critical of management of Langerhans Cell Histiocytosis in adults 65
Alte dosi di ARA-C + Idarubicina nel trattamento della leucemia linfoide acuta in fase avanzata 64
null 64
Bcl-2 and mTOR as Effective Targets for Molecular Therapy of Acute Lymphoblastic Leukemia. 64
Long-term follow-up of Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in children and adolescents managed at a single institution over a 20-year period 64
Intermittent Imatinib mesylate in children with chronic myeloid leukemia: results and outcome 64
Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty. 63
Trisomy 13 in a patient with common acute lymphoblastic leukemia. Description of a case and review of the literature. 62
null 62
A single high dose of idarubicin combined with high-dose ABA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of Rome. 62
Treatment of Children With B-Cell Non-Hodgkin Lymphoma in a Low-Income Country 60
null 59
Therapeutic strategies for postremission treatment in childhood acute myeloid leukemia (AML). The AIEOP experience 1987-1991. 58
GIMEMA-AIEOP AIDA protocols for the treatment of newly diagnosed acute promyelocytic leukemia APL) in children: analysis of patients enrolled in two sequential Italian multicenter trials 58
A single high dose of idarubicin combined with high-dose ARA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University "La Sapienza" of Rome. 58
Proven Epstein-Barr encephalitis with negative EBV-DNA load in cerebrospinal fluid after allogeneic hematopoietic stem cell transplantation in a child with acute lymphoblastic leukemia 58
Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood 57
Acute lymphoblastic leukemia (ALL) primary refractory or in first relapse: results in children and adults over a 20-year period. 57
Juvenile chronic myeloid leukemia (CML): A single center 20-year experience. 57
Difference in outcome of adolescents with acute lymphoblastic leukemia (ALL) enrolled in pediatric (AIEOP) and adult (GIMEMA) protocols 57
Idarubicin plus Cytosine-Arabinoside (ALL R-87 Protocol) in advanced acute lymphoblastic leukemia: the GIMEMA/AIEOP experience. 57
Results of the AIEOP-BFM ALL 2000 Study for Childhood Acute Lymphoblastic Leukemia IN AIEOP High Risk Patients 57
Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP experience. 56
null 56
Can patients with epilepsy become bone marrow donors? A case report of allogeneic hematopoietic stem transplantation from child with seizures 56
KIT gene deletion in a gastrointestinal stromal tumor of the small intestine. 55
Listeriosis in recipients of allogeneic bone marrow transplants from unrelated donors 55
Acute promyelocytic leukemia (APL) in children: results of the AIDA Italian protocol. 55
Polyostotic Fibrous Dysplasia Mimicking Bone Involvement in Hodgkin Lymphoma: A Pediatric Case and Literature Review 55
Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation 54
Myelodysplastic syndromes in childhood: Description of seven cases 54
Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature. 54
null 54
Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: An immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells. 54
Evaluation of a polychemotherapeutic regimen including Idarubicin (4-demethoxydaunorubicin) in relapsed acute lymphocytic leukemia. 53
null 53
Heterogeneity of TdT+, HLA-DR+ acute leukaemia: immunological, immunocytochemical and clinical evidence of lymphoid and myeloid origin. 53
Applicazione della classificazione WHO 2016 IN 80 bambini e adolescenti con neoplasie mieloproliferative croniche 52
Next-Generation Sequencing (NGS) in childhood Myeloproliferative Diseases (MPD) 52
Trombocitopenia Idiopatica (ITP) cronica. cosa puo’ nascondere? 52
Chronic Thrombocytopenia in Children: What Could It Hide? 52
null 51
Adult acute lymphoblastic leukemia (ALL) refractory or in relapse: results of treatment over a 17-year period 51
Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. 51
Therapy of childhood Acute Myelogenous Leukemia: an update of the AIEOP/LAM 8204 Study 51
Risultati di uno studio randomizzato con prednisone a basse o alte dosi in bambini e adolescenti con porpora trombocitopenia idiopatica (PTI). [RESULTS OF A RANDOMIZED TRIAL WITH PREDNISONE AT LOW OR HIGH DOSES IN CHILDREN AND ADOLESCENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA] 51
Clinical and Biological Features, Treatment and Long-Term Outcome of 65 Children with Ph- Myeloprolipherative Disorders (MPD). 50
Autoimmune Hemolytic Anemia and Immune Thrombocytopenia as Unusual Presentations of Childhood Hodgkin Lymphoma: A Case Report and Review of the Literature 50
Langerhans cell histiocytosis in childhood: results from the Italian Cooperative AIEOP-CNR-H.X '83 study. 50
"Southern blot analysis as ALL-I rearrangements at chromosome 11q23 in acute leucemia" 49
Clinico-biologic features of 5202 acute lymphoblastic leukemia patients enrolled in the Italian AIEOP and GIMEMA Protocols and stratified in age-cohorts. 49
Acute lymphoblastic leukemia (ALL) primary refractory or in first relapse: results in children and adults over a 20-year period 49
Totale 9.433
Categoria #
all - tutte 43.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.757


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.551 0 0 0 0 0 298 295 265 208 232 162 91
2020/20211.059 95 94 42 114 69 45 65 144 130 82 132 47
2021/20223.040 41 169 247 206 459 78 56 244 237 260 338 705
2022/20233.546 867 462 145 371 330 504 81 197 338 43 135 73
2023/20241.973 112 206 112 117 124 116 93 353 32 267 199 242
2024/20251.633 240 395 204 186 337 271 0 0 0 0 0 0
Totale 16.897